# US 2009/0253117 A1 · Enzymatic substrates for multiple detection systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0253117 A1
- Document ID: US20090253117A1
- Status: Published application
- Kind: A1
- Application number: 12/403,790
- Filed: 2009-03-13
- Published: 2009-10-08
- Earliest claimed: 2008-03-13
- Assignees: PerkinElmer Health Sciences, Inc.
- Inventors: Blas Cerda; Mark Norman Bobrow
- Web page: https://patentgrep.com/patent/US20090253117A1

## CPC

- C12Q 1/34: involving hydrolase
- C07C 237/22: having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated (peptides C07K)
- C07H 15/203: Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
- C07K 5/06: Dipeptides
- C07K 19/00: Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}
- G01N 2333/924: acting on glycosyl compounds (3.2)
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An inventive substrate is provided which includes a substrate compound of formula A-B1-B2-B3-B4: wherein A is a sugar moiety; B1 is a linker moiety allowing the conjugation of moiety A and the remaining structure of the substrate; B2 is a linker moiety with a free reactive amino group so as to be available for reaction with carboxylic acids or detectable tags; B3 contains a permanently charged element such as a quaternary ammonium group so as to increase sensitivity for mass spectrometry analysis; and B4 of various carbon length conferring specificity amongst individual substrates in detection methods. Also provided is a molecule of the formula B1-B2-B3-B4, with similar structural characteristics to an enzymatic product produced by the action of a target enzyme on an inventive substrate. Further provided are methods for using inventive substrates for detecting enzymatic activity.

## Claims

### Claim 1

A substrate for analysis of an enzyme having formula:
A-(B1-B2-B3-B4) (I)
where A is a monosaccharide or a disaccharide and B1 is a C1-C20 alkyl, C1-C20 having a substituted C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S; B2 is an amino acid; 2,6-diaminohexanoic acid; or
where R1′ is a C1-C20 alkyl; C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; heteroatom C6-C20 aryl, C1-C20 carbonyl, C1-C20 amidyl, C1-C20 ether, C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O, or S; X is a nullity, oxygen, sulfur, or nitrogen; R2′ is a nullity or C1-C20 alkyl, C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; C1-C20 ester; C1-C20 alcohol; C1-C20 alkenyl; heteroatom C1-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S; Y is a carbon, nitrogen, oxygen, or sulfur nucleophilic group; and n is an integer between 1 and 30.
B3 is
where R1 is a C1-C20 alkyl; C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; heteroatom C6-C20 aryl, C1-C20 carbonyl, C1-C20 amidyl, C1-C20 ether, C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O, or S; R2 is independently in each occurrence a H, a C1-C20 alkyl, a C2-C20 alkyl having a substituent of C1-C20 alkyl; X is independently in each occurrence a nullity, oxygen, sulfur, or nitrogen; R3 is independently in each occurrence a nullity, C1-C20 alkyl, C1-C20 having a substituted C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S; n is an integer between 0 and 30, inclusive; R4 is independently in each occurrence a nullity, C1-C20 alkyl, C1-C20 having a substituted C6-C20 aryl, C1-C20 carbonyl, C1-C20 amidyl, C1-C20 ether, C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O, or S; and B4 is a nullity or C1-C20 alkyl, C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; C1-C20 ester; C1-C20 alcohol; C4-C20 alkenyl; heteroatom C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S.

### Claim 2 (depends on 1)

The substrate of claim 1 wherein a and (B1-B2-B3-B4) are separated by an action of said enzyme.

### Claim 3 (depends on 1)

The substrate of claim 1 wherein a is an aldohexose or a ketohexose.

### Claim 4 (depends on 1)

The substrate of claim 1 wherein a is a D-glucose or a D-galactose.

### Claim 5 (depends on 1)

The substrate of claim 1 wherein B1 is C6 aryl having die substituent extending from the ring.

### Claim 6 (depends on 1)

The substrate of claim 1 where B2 is a lysine.

### Claim 7 (depends on 1)

The substrate of claim 1 wherein B2 is derivatized by die addition of a fluorophore.

### Claim 8 (depends on 1)

The substrate of claim 1 wherein B3 is a carnitinyl.

### Claim 9 (depends on 8)

The substrate of claim 8 wherein B4 is C2-C20 alkyl having a substituent of O present as a carbonyl.

### Claim 10 (depends on 1)

The substrate of claim 1 wherein A and (B1-B2-B3-B4) portions each include a stable secondary prevalence isotope of an element.

### Claim 11 (depends on 10)

The substrate of claim 10 wherein said stable secondary prevalence isotope in each occurrence is selected from die group consisting of 2D, 13C, 15N, 17O, 18O, 31P and 34S.

### Claim 12

A molecule having formula:
B1-B2-B3-B4 (I)
where B1 is a C1-C20 alkyl, C1-C20 having a substituted C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S; B2 is an amino acid; 2,6-diaminohexanoic acid; or
where R1′ is a C1-C20 alkyl; C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; heteroatom C6-C20 aryl, C1-C20 carbonyl, C1-C20 amidyl, C1-C20 ether, C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O, or S; X is a nullity, oxygen, sulfur, or nitrogen; R2′ is a nullity or C1-C20 alkyl, C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; C1-C20 ester; C1-C20 alcohol; C1-C20 alkenyl; heteroatom C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S; Y is a carbon, nitrogen, oxygen, or sulfur nucleophilic group; and n is an integer between 1 and 30.
B3 is
where R1 is a C1-C20 alkyl; C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; heteroatom C6-C20 aryl, C1-C20 carbonyl, C1-C20 amidyl, C1-C20 ether, C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O, or S; R2 is independently in each occurrence a H, a C1-C20 alkyl, a C2-C20 alkyl having a substituent of C1-C20 alkyl; X is independently in each occurrence a nullity, oxygen, sulfur, or nitrogen; R3 is independently in each occurrence a nullity, C1-C20 alkyl, C1-C20 having a substituted C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S; n is an integer between 0 and 30, inclusive; R4 is independently in each occurrence a nullity, C1-C20 alkyl, C1-C20 having a substituted C6-C20 aryl, C1-C20 carbonyl, C1-C20 amidyl, C1-C20 ether, C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O, or S; and B4 is a nullity or C1-C20 alkyl, C4-C20 ether; C1-C20 alkyl having a substituent of N, O, or S; C1-C20 ester; C1-C20 alcohol; C4-C20 alkenyl; heteroatom C6-C20 aryl, C6-C20 heterocyclic containing a heteroatom of N, O or S.

### Claim 13 (depends on 12)

The molecule of claim 12 wherein B1 is C6 aryl having the substituent extending from die ring.

### Claim 14 (depends on 12)

The molecule of claim 12 where B2 is a lysine.

### Claim 15 (depends on 12)

The molecule of claim 12 wherein B2 is derivatized by die addition of a fluorophore.

### Claim 16 (depends on 12)

The molecule of claim 12 wherein B3 is a carnitinyl.

### Claim 17 (depends on 12)

The molecule of claim 12 wherein B4 is C2-C20 alkyl having a substituent of O present as a carbonyl.

### Claim 18 (depends on 12)

The molecule of claim 12 wherein B1-B2-B3-B4) includes a stable secondary prevalence isotope of an element.

### Claim 19 (depends on 18)

The molecule of claim 18 wherein said stable secondary prevalence isotope in each occurrence is selected from the group consisting of 2D, 13C, 13N, 17O, 18O, 31P and 34S.

### Claim 20 (depends on 1)

A method for detecting enzymatic activity, comprising: contacting a sample containing a target enzyme with a substrate of claim 1, wherein said substrate is linked to a solid support, under conditions wherein die target enzyme is capable of acting on the substrate to produce an enzymatic product; and detecting the amount of substrate remaining on die solid support.
